Considering the multiple analyses undertaken with multiple forms of the exposure variable (for example APOE*ε4 carrier, number of ε4 alleles) and multiple outcomes measures (for example symptomology, any depression, minor or major depression), we conclude that there is no systematic evidence for the role APOE*ε4 in depression risk across the adult lifespan. Here, APOE is linked to depressive symptom measurement.